|
|
Volumn 9, Issue 11, 2001, Pages 3041-3047
|
|
3-Hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 HYDROXY 2 METHYL 4H BENZOPYRAN 4 ONE;
BENZOPYRAN DERIVATIVE;
CHELATING AGENT;
DEFEROXAMINE;
UNCLASSIFIED DRUG;
2 METHYL 3 HYDROXY 4H BENZOPYRAN 4 ONE;
3 HYDROXY 4H BENZOPYRAN 4 ONE DERIVATIVE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CELL MEMBRANE PERMEABILITY;
CONTROLLED STUDY;
CYCLIC POTENTIOMETRY;
DRUG DESIGN;
DRUG EXCRETION;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG UPTAKE;
EHRLICH ASCITES TUMOR CELL;
ERYTHROCYTE;
IN VITRO STUDY;
IRON CHELATION;
LIPOPHILICITY;
LIVER LEVEL;
MALE;
MASS SPECTROMETRY;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE;
RAT;
SPECTROPHOTOMETRY;
X RAY CRYSTALLOGRAPHY;
ASCITES TUMOR CELL;
CRYSTAL STRUCTURE;
DRUG LIVER LEVEL;
DRUG PENETRATION;
DRUG URINE LEVEL;
ADMINISTRATION, ORAL;
ANIMALS;
BENZOPYRANS;
CHROMONES;
DRUG DESIGN;
ERYTHROCYTES;
FECES;
IRON CHELATING AGENTS;
LIVER;
MALE;
MOLECULAR STRUCTURE;
RATS;
RATS, SPRAGUE-DAWLEY;
TUMOR CELLS, CULTURED;
URINE;
|
|
EID: 0034810372
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(01)00207-3 Document Type: Article |
|
Times cited : (39)
|
|
References (29)
|
